Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob Rudd who wrote (20773)	3/16/2005 2:38:42 PM
From: Bob Rudd	Read Replies (1) of 78714

BIIB - SOLD 'You gotta know when to fold'em' Avonex is 2/3's of Biogen's current revenue. News just hit that it would get likely get a big ugly black box warning for liver damage. I was expecting Avonex to be helped somewhat...or at least be stable in the wake of the Tysabri disaster. I don't know what the fallout from this will be, but this is too much at risk to wait and find out. Amazing. This drug was on the market for 8 years with no negatives other than in combination with Tysabri...then suddenly the trap door opens and down it goes. I feel sorry for MS patients who will be left in a lurch by this.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next